The A.I. story nobody is telling you (Read ASAP)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Myron Wentz Biography and Net Worth

Major Shareholder of USANA Health Sciences

Myron Wentz, Ph.D. is the founder and former chairman and CEO of USANA Health Sciences. He continues to hold the title of chairman emeritus for the company, after retiring in May 2020.

Dr. Wentz is a globally renowned microbiologist, immunologist, and pioneer in the development of human cell culture technology and infectious disease diagnoses. His career trajectory was inspired by a passion for the life sciences and his personal experiences, including his father’s death from heart disease when he was just 17, as well as other family members who suffered from degenerative diseases.

In 1974, he started Gull Laboratories, where he developed many of the world’s first FDA-approved laboratory assays for viral diseases. He is best known for the development of the Epstein-Barr diagnostic test, which remains the world’s gold standard for diagnosing that virus.

Dr. Wentz went on to sell the controlling interest in Gull Laboratories to a German medical products firm, and in 1992, he created USANA Health Sciences. His goal was to fight degenerative diseases through the development of advanced nutritional products. In 2000, he founded Sanoviv Medical Institute, a model holistic and integrative medical center in Baja California, Mexico.

Dr. Wentz authored A Mouth Full of Poison, Invisible Miracles, and co-authored the best-selling book, The Healthy Home. He is also the author of numerous scientific papers. Throughout his career, Dr. Wentz has been recognized with various awards and accolades, including the inaugural Children’s Hunger Fund Lifetime Achievement Award in 2016, the Albert Einstein Award for Outstanding Achievement in the Life Sciences in 2007, the Children’s Hunger Fund Children’s Champion Award in 2006, and the Ernst & Young Entrepreneur of the Year Award in 2003, among others.

In honor of his commitment to philanthropy, he was the inspiration for the USANA Foundation, a charity focused on helping those suffering from hunger and malnutrition. Dr Wentz founded the Wentz Medical Center and Laboratory in Uganda, as well as the Wentz Medical Center in Cambodia, both of which serve children orphaned by diseases like HIV and malaria. He has also worked with the Children’s Hunger Fund to establish medical centers in other underserved countries and regions.

He also helped fund the creation of several Mercy Centers and has pledged funds for more to be established. Additionally, Dr. Wentz is a generous donor to his alma mater, North Central College.

Dr. Wentz earned his bachelor's degree in biology from North Central in Naperville, Illinois, his master's degree in microbiology from the University of North Dakota, and his Ph.D. in microbiology and immunology from the University of Utah in Salt Lake City.

What is Myron W. Wentz's net worth?: The estimated net worth of Myron W. Wentz is at least $427.68 million as of January 2nd, 2019. Dr. Wentz owns 9,918,483 shares of USANA Health Sciences stock worth more than $427,684,987 as of April 26th. This net worth evaluation does not reflect any other assets that Dr. Wentz may own. Learn More about Myron W. Wentz's net worth.
How old is Myron W. Wentz?: Dr. Wentz is currently 83 years old. There are 7 older executives and no younger executives at USANA Health Sciences. Learn More on Myron W. Wentz's age.
How do I contact Myron W. Wentz?: The corporate mailing address for Dr. Wentz and other USANA Health Sciences executives is 3838 West Parkway Blvd, Salt Lake City UT, 84120. USANA Health Sciences can also be reached via phone at (801) 954-7100 and via email at [email protected]. Learn More on Myron W. Wentz's contact information.
Has Myron W. Wentz been buying or selling shares of USANA Health Sciences?: Myron W. Wentz has not been actively trading shares of USANA Health Sciences within the last three months. Most recently, Myron W. Wentz sold 600,000 shares of the business's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $80.00, for a transaction totalling $48,000,000.00. Learn More on Myron W. Wentz's trading history.
Who are USANA Health Sciences' active insiders?: USANA Health Sciences' insider roster includes Robert Auciaux (Director), Jim Brown (President), John Fleming (Director), Joshua Foukas (Insider), Gilbert Fuller (Director), G. Iiekking (CFO), Daniel Macuga (Insider), David Mulham (Insider), Brent Neidig (Insider), Walter Noot (COO), Feng Peng (Director), Robert Sinnott (Insider), Myron Wentz (Major Shareholder), and Frederic Winssinger (Director). Learn More on USANA Health Sciences' active insiders.
Are insiders buying or selling shares of USANA Health Sciences?: In the last twelve months, insiders at the sold shares 20 times. They sold a total of 59,164 shares worth more than $3,449,714.61. The most recent insider tranaction occured on March, 11th when Chairman Kevin Guest sold 11,011 shares worth more than $539,539.00. Insiders at USANA Health Sciences own 0.3% of the company. Learn More about insider trades at USANA Health Sciences.
Information on this page was last updated on 3/11/2024.

Myron W. Wentz Insider Trading History at USANA Health Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/21/2020	Sell	600,000	$80.00	$48,000,000.00
5/5/2020	Sell	641,270	$80.75	$51,782,552.50
2/4/2019	Sell	9,355	$115.77	$1,083,028.35
2/1/2019	Sell	20,645	$115.36	$2,381,607.20
1/4/2019	Sell	9,557	$114.43	$1,093,607.51
1/2/2019	Sell	9,931	$116.48	$1,156,762.88	9,918,483
12/7/2018	Buy	6,697	$70.46	$471,870.62
12/4/2018	Sell	30,000	$120.56	$3,616,800.00
11/1/2018	Sell	25,464	$114.36	$2,912,063.04
10/1/2018	Sell	30,000	$119.89	$3,596,700.00
9/6/2018	Sell	5,688	$124.27	$706,847.76
9/4/2018	Sell	19,933	$128.26	$2,556,606.58	10,048,831
8/8/2018	Sell	50,000	$131.05	$6,552,500.00
8/6/2018	Sell	150,000	$131.20	$19,680,000.00
8/3/2018	Sell	50,000	$131.60	$6,580,000.00
8/1/2018	Sell	25,362	$128.06	$3,247,857.72
7/3/2018	Sell	40,000	$115.24	$4,609,600.00
6/4/2018	Sell	44,285	$115.36	$5,108,717.60
6/1/2018	Sell	40,000	$115.13	$4,605,200.00
5/30/2018	Sell	107,670	$115.98	$12,487,566.60
5/25/2018	Sell	100,000	$115.00	$11,500,000.00
5/23/2018	Sell	4,144	$120.86	$500,843.84	11,025,753
3/12/2018	Sell	228,000	$81.10	$18,490,800.00
3/9/2018	Sell	78,129	$81.19	$6,343,293.51
3/2/2018	Sell	28,050	$76.14	$2,135,727.00
2/15/2018	Sell	53,372	$76.01	$4,056,805.72
2/13/2018	Sell	28,405	$75.39	$2,141,452.95
2/6/2018	Sell	38,223	$71.51	$2,733,326.73
11/21/2017	Sell	164,916	$66.40	$10,950,422.40
11/17/2017	Sell	7,895	$66.03	$521,306.85
11/15/2017	Sell	11,835	$66.07	$781,938.45
11/13/2017	Sell	5,304	$66.01	$350,117.04	12,011,418
11/9/2017	Sell	1,985	$66.01	$131,029.85	12,011,418
11/1/2017	Sell	17,107	$65.42	$1,119,139.94
10/30/2017	Sell	21,209	$66.11	$1,402,126.99
10/3/2017	Sell	40,000	$57.54	$2,301,600.00
9/15/2017	Sell	28,788	$57.19	$1,646,385.72
9/14/2017	Sell	34,226	$57.51	$1,968,337.26
8/2/2017	Sell	40,000	$56.59	$2,263,600.00
7/5/2017	Sell	40,000	$64.15	$2,566,000.00
6/2/2017	Sell	40,000	$64.99	$2,599,600.00
5/1/2017	Sell	40,000	$56.39	$2,255,600.00
4/5/2017	Sell	40,000	$56.81	$2,272,400.00
1/11/2017	Sell	20,000	$61.04	$1,220,800.00
12/14/2016	Sell	20,000	$61.41	$1,228,200.00
11/9/2016	Sell	10,000	$123.99	$1,239,900.00
3/9/2016	Sell	10,000	$116.07	$1,160,700.00
12/9/2015	Sell	10,000	$133.18	$1,331,800.00
10/1/2015	Sell	10,000	$131.85	$1,318,500.00
9/10/2015	Sell	7,000	$138.32	$968,240.00
8/12/2015	Sell	7,000	$159.84	$1,118,880.00
7/8/2015	Sell	7,000	$138.28	$967,960.00
6/10/2015	Sell	7,000	$133.75	$936,250.00
1/14/2015	Sell	7,000	$101.32	$709,240.00
12/10/2014	Sell	102,755	$100.25	$10,301,188.75
12/8/2014	Sell	184,245	$104.65	$19,281,239.25
10/8/2014	Sell	7,000	$76.52	$535,640.00
9/10/2014	Sell	7,000	$71.53	$500,710.00
7/9/2014	Sell	7,000	$78.95	$552,650.00
6/11/2014	Sell	7,000	$74.69	$522,830.00
8/8/2012	Sell	7,000	$44.21	$309,470.00

Myron W. Wentz Buying and Selling Activity at USANA Health Sciences

USANA Health Sciences Company Overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $43.76

$43.33

$43.76

50 Day Range

MA: $47.31

$43.01

$50.17

2 Week Range

Now: $43.76

$42.59

$69.60

Volume

10,853 shs

Average Volume

79,863 shs

Market Capitalization

$841.94 million

P/E Ratio

13.26

Dividend Yield

N/A

Beta

0.91

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad